Nymox Pharmaceutical Corp SEC filings NYMXF
Nymox Pharmaceutical Corp has 408 filings in SEC EDGAR's recent list, going back to Aug 8, 1996. Its latest annual report, Form 20-F, was filed on Sep 14, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Aug 31, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 20-F/A | Amended annual report (foreign issuer) | Sep 29, 2026 | Dec 31, 2025 |
| 20-F/A | Amended annual report (foreign issuer) | Sep 16, 2026 | Dec 31, 2025 |
| 20-F | Annual report (foreign issuer) | Sep 14, 2026 | Dec 31, 2025 |
| 6-K | Current report (foreign issuer) | Aug 31, 2026 | Aug 31, 2026 |
| 6-K | Current report (foreign issuer) | Aug 7, 2026 | Aug 7, 2026 |
| 6-K | Current report (foreign issuer) | Jun 3, 2026 | Jun 2, 2026 |
| 6-K | Current report (foreign issuer) | Mar 27, 2026 | Mar 27, 2026 |
| 6-K | Current report (foreign issuer) | Nov 7, 2025 | Nov 7, 2025 |
| 6-K | Current report (foreign issuer) | Oct 22, 2025 | Oct 22, 2025 |
| 6-K | Current report (foreign issuer) | Oct 22, 2025 | Oct 22, 2025 |
| 6-K | Current report (foreign issuer) | Sep 23, 2025 | Sep 23, 2025 |
| 20-F | Annual report (foreign issuer) | Jun 3, 2025 | Dec 31, 2024 |
| 6-K | Current report (foreign issuer) | May 22, 2025 | May 22, 2025 |
| NT 20-F | Form 20-f | May 1, 2025 | Dec 31, 2024 |
| 6-K | Current report (foreign issuer) | Mar 11, 2025 | Mar 11, 2025 |
| 6-K | Current report (foreign issuer) | Jan 2, 2025 | Sep 30, 2024 |
| 6-K | Current report (foreign issuer) | Dec 17, 2024 | Dec 17, 2024 |
| 20-F | Annual report (foreign issuer) | Aug 29, 2024 | Dec 31, 2023 |
| 6-K | Current report (foreign issuer) | Jul 18, 2024 | Jul 18, 2024 |
| 6-K | Current report (foreign issuer) | Jul 16, 2024 | Jul 17, 2024 |
| 6-K | Current report (foreign issuer) | May 13, 2024 | May 13, 2024 |
| 6-K | Current report (foreign issuer) | Mar 28, 2024 | Mar 28, 2024 |
| 6-K | Current report (foreign issuer) | Nov 15, 2023 | Sep 30, 2023 |
| 6-K | Current report (foreign issuer) | Nov 9, 2023 | Nov 9, 2023 |
| 6-K | Current report (foreign issuer) | Nov 6, 2023 | Nov 3, 2023 |
| 6-K | Current report (foreign issuer) | Oct 26, 2023 | Oct 26, 2023 |
| 6-K | Current report (foreign issuer) | Sep 25, 2023 | Sep 25, 2023 |
| 25-NSE | Delisting notice | Sep 8, 2023 | — |
| 6-K | Current report (foreign issuer) | Aug 29, 2023 | Aug 29, 2023 |
| 6-K | Current report (foreign issuer) | Aug 14, 2023 | Jun 30, 2023 |
| 6-K | Current report (foreign issuer) | Aug 2, 2023 | Aug 2, 2023 |
| 6-K | Current report (foreign issuer) | Jul 31, 2023 | Jul 31, 2023 |
| 6-K | Current report (foreign issuer) | Jul 25, 2023 | Jul 25, 2023 |
| 6-K | Current report (foreign issuer) | Jul 25, 2023 | Jul 25, 2023 |
| 6-K | Current report (foreign issuer) | Jul 12, 2023 | Jul 12, 2023 |
| 6-K | Current report (foreign issuer) | Jul 6, 2023 | Jul 5, 2023 |
| 6-K | Current report (foreign issuer) | Jun 29, 2023 | Jun 29, 2023 |
| 6-K/A | Form 6-k/a | Jun 29, 2023 | Jun 28, 2023 |
| 6-K | Current report (foreign issuer) | Jun 27, 2023 | Jun 27, 2023 |
| 6-K | Current report (foreign issuer) | May 12, 2023 | Mar 31, 2023 |
| 20-F | Annual report (foreign issuer) | May 2, 2023 | Dec 31, 2022 |
| NT 20-F | Filing | Mar 31, 2023 | Dec 31, 2022 |
| 6-K | Current report (foreign issuer) | Jan 6, 2023 | Jan 4, 2023 |
| 6-K/A | Form 6-k/a | Nov 16, 2022 | Nov 10, 2022 |
| 6-K/A | Form 6-ka | Nov 16, 2022 | Sep 30, 2022 |
| 6-K | Current report (foreign issuer) | Nov 14, 2022 | Sep 30, 2022 |
| 6-K | Current report (foreign issuer) | Nov 14, 2022 | Nov 10, 2022 |
| 6-K | Current report (foreign issuer) | Aug 15, 2022 | Jun 30, 2022 |
| 6-K | Current report (foreign issuer) | Jul 8, 2022 | Jun 28, 2022 |
| 6-K | Current report (foreign issuer) | May 13, 2022 | Mar 31, 2022 |
| EFFECT | Filing | Apr 12, 2022 | — |
| CORRESP | Letter to the SEC | Apr 6, 2022 | — |
| UPLOAD | Letter from the SEC | Apr 4, 2022 | — |
| 20-F | Annual report (foreign issuer) | Mar 30, 2022 | Dec 31, 2021 |
| F-3 | Shelf registration (foreign issuer) | Mar 29, 2022 | — |
| 6-K | Current report (foreign issuer) | Mar 22, 2022 | Mar 22, 2022 |
| 424B5 | Prospectus supplement | Mar 22, 2022 | — |
| EFFECT | Filing | Jan 28, 2022 | — |
| CORRESP | Letter to the SEC | Jan 25, 2022 | — |
| UPLOAD | Letter from the SEC | Dec 22, 2021 | — |
| F-3 | Shelf registration (foreign issuer) | Dec 9, 2021 | — |
| 6-K/A | Form 6-k-a | Nov 22, 2021 | Nov 19, 2021 |
| 6-K | Current report (foreign issuer) | Nov 19, 2021 | Nov 19, 2021 |
| 6-K | Current report (foreign issuer) | Nov 12, 2021 | Sep 30, 2021 |
| 6-K | Current report (foreign issuer) | Aug 13, 2021 | Jun 30, 2021 |
| 20-F/A | Amended annual report (foreign issuer) | Jun 11, 2021 | Dec 31, 2020 |
| EFFECT | Filing | May 20, 2021 | — |
| CORRESP | Letter to the SEC | May 17, 2021 | — |
| 6-K | Current report (foreign issuer) | May 14, 2021 | Mar 31, 2021 |
| UPLOAD | Letter from the SEC | May 14, 2021 | — |
| F-3 | Shelf registration (foreign issuer) | May 12, 2021 | — |
| 6-K | Current report (foreign issuer) | May 6, 2021 | Apr 30, 2021 |
| 20-F | Annual report (foreign issuer) | Mar 29, 2021 | Dec 31, 2020 |
| 6-K | Current report (foreign issuer) | Nov 20, 2020 | Nov 19, 2020 |
| 6-K | Current report (foreign issuer) | Nov 19, 2020 | Nov 18, 2020 |
| 6-K | Current report (foreign issuer) | Nov 13, 2020 | Sep 30, 2020 |
| 6-K | Current report (foreign issuer) | Oct 13, 2020 | Oct 13, 2020 |
| 6-K | Current report (foreign issuer) | Aug 14, 2020 | Aug 14, 2020 |
| 6-K | Current report (foreign issuer) | Aug 14, 2020 | Jun 30, 2020 |
| 424B5 | Prospectus supplement | Aug 14, 2020 | — |
| 424B5 | Prospectus supplement | Aug 14, 2020 | — |
| 6-K | Current report (foreign issuer) | Aug 13, 2020 | Aug 11, 2020 |
| 6-K | Current report (foreign issuer) | Aug 12, 2020 | Aug 12, 2020 |
| 6-K | Current report (foreign issuer) | Jul 20, 2020 | Jul 17, 2020 |
| 424B5 | Prospectus supplement | Jul 17, 2020 | — |
| 6-K | Current report (foreign issuer) | May 14, 2020 | Mar 31, 2020 |
| EFFECT | Filing | May 12, 2020 | — |
| CORRESP | Letter to the SEC | May 7, 2020 | — |
| F-3/A | Filing | May 6, 2020 | — |
| F-3/A | Form f-3/a | Apr 24, 2020 | — |
| 6-K | Current report (foreign issuer) | Apr 24, 2020 | Apr 23, 2020 |
| UPLOAD | Letter from the SEC | Apr 10, 2020 | — |
| F-3 | Shelf registration (foreign issuer) | Apr 3, 2020 | — |
| 20-F | Annual report (foreign issuer) | Mar 30, 2020 | Dec 31, 2019 |
| 6-K | Current report (foreign issuer) | Nov 19, 2019 | Nov 19, 2019 |
| 6-K | Current report (foreign issuer) | Nov 13, 2019 | Sep 30, 2019 |
| 6-K | Current report (foreign issuer) | Aug 14, 2019 | Jun 30, 2019 |
| 6-K | Current report (foreign issuer) | May 15, 2019 | Mar 31, 2019 |
| 20-F | Annual report (foreign issuer) | Mar 29, 2019 | Dec 31, 2018 |
| 6-K | Current report (foreign issuer) | Nov 26, 2018 | Nov 23, 2018 |
| 6-K | Current report (foreign issuer) | Nov 13, 2018 | Sep 30, 2018 |
| 6-K | Current report (foreign issuer) | Aug 13, 2018 | Jun 30, 2018 |
| 6-K | Current report (foreign issuer) | May 15, 2018 | Mar 31, 2018 |
| 20-F/A | Amended annual report (foreign issuer) | May 11, 2018 | Dec 31, 2017 |
| 6-K | Current report (foreign issuer) | Apr 26, 2018 | Apr 26, 2018 |
| 20-F | Annual report (foreign issuer) | Mar 30, 2018 | Dec 31, 2017 |
| 6-K | Current report (foreign issuer) | Dec 4, 2017 | Dec 1, 2017 |
| 6-K | Current report (foreign issuer) | Nov 6, 2017 | Sep 30, 2017 |
| 6-K | Current report (foreign issuer) | Aug 8, 2017 | Aug 4, 2017 |
| 6-K | Current report (foreign issuer) | May 16, 2017 | May 15, 2017 |
| 20-F | Annual report (foreign issuer) | Mar 31, 2017 | Dec 31, 2016 |
| 6-K | Current report (foreign issuer) | Nov 23, 2016 | Nov 23, 2016 |
| UPLOAD | Letter from the SEC | Nov 21, 2016 | — |
| 6-K | Current report (foreign issuer) | Nov 15, 2016 | Sep 30, 2016 |
| CORRESP | Letter to the SEC | Nov 15, 2016 | — |
| UPLOAD | Letter from the SEC | Nov 1, 2016 | — |
| UPLOAD | Letter from the SEC | Sep 21, 2016 | — |
| 6-K | Current report (foreign issuer) | Aug 22, 2016 | Jun 30, 2016 |
| 6-K | Current report (foreign issuer) | May 16, 2016 | Mar 31, 2016 |
| 20-F | Annual report (foreign issuer) | Mar 31, 2016 | Dec 31, 2015 |
| 6-K | Current report (foreign issuer) | Feb 9, 2016 | Feb 9, 2016 |
| 424B5 | Prospectus supplement | Feb 9, 2016 | — |
| 6-K | Current report (foreign issuer) | Feb 9, 2016 | Feb 8, 2016 |
| 6-K | Current report (foreign issuer) | Feb 4, 2016 | Feb 4, 2016 |
| 6-K | Current report (foreign issuer) | Dec 31, 2015 | Sep 30, 2015 |
| 6-K/A | Report of foreign issuer for the period ended june 30, 2015 | Dec 31, 2015 | Jun 30, 2015 |
| 6-K | Current report (foreign issuer) | Dec 31, 2015 | Dec 22, 2015 |
| 6-K | Current report (foreign issuer) | Nov 25, 2015 | Nov 24, 2015 |
| 6-K | Current report (foreign issuer) | Nov 23, 2015 | Dec 16, 2015 |
| 6-K | Current report (foreign issuer) | Aug 24, 2015 | Jun 30, 2015 |
| 6-K | Current report (foreign issuer) | Aug 7, 2015 | Aug 7, 2015 |
| EFFECT | Filing | Aug 4, 2015 | — |
| CORRESP | Letter to the SEC | Aug 4, 2015 | — |
| 6-K | Current report (foreign issuer) | Jul 28, 2015 | Jun 30, 2015 |
| F-3/A | Amendment no. 1 to form f-3 registration statement | Jul 24, 2015 | — |
| UPLOAD | Letter from the SEC | Jul 24, 2015 | — |
| 6-K | Current report (foreign issuer) | Jul 20, 2015 | Jul 17, 2015 |
| 6-K | Current report (foreign issuer) | Jul 17, 2015 | Jul 16, 2015 |
| F-3 | Shelf registration (foreign issuer) | Jul 14, 2015 | — |
| 6-K | Current report (foreign issuer) | May 15, 2015 | Mar 31, 2015 |
| 6-K | Current report (foreign issuer) | Apr 3, 2015 | Apr 23, 2015 |
| 6-K | Current report (foreign issuer) | Mar 31, 2015 | Dec 31, 2014 |
| 20-F | Annual report (foreign issuer) | Mar 31, 2015 | Dec 31, 2014 |
| 6-K | Current report (foreign issuer) | Mar 25, 2015 | Mar 24, 2015 |
| 6-K | Current report (foreign issuer) | Mar 25, 2015 | Mar 10, 2015 |
| 6-K | Current report (foreign issuer) | Dec 19, 2014 | Dec 18, 2014 |
| 6-K | Current report (foreign issuer) | Dec 19, 2014 | Dec 18, 2014 |
| 6-K | Current report (foreign issuer) | Nov 14, 2014 | Sep 30, 2014 |
| 6-K | Current report (foreign issuer) | Nov 4, 2014 | Nov 2, 2014 |
| 6-K | Current report (foreign issuer) | Aug 11, 2014 | Jun 30, 2014 |
| 6-K | Current report (foreign issuer) | Jul 22, 2014 | Jul 22, 2014 |
| 6-K | Current report (foreign issuer) | May 15, 2014 | Mar 31, 2014 |
| 6-K | Current report (foreign issuer) | May 6, 2014 | May 6, 2014 |
| 6-K | Current report (foreign issuer) | Apr 30, 2014 | Apr 30, 2014 |
| 6-K/A | Report of foreign issuer for the month of april 2014 | Apr 21, 2014 | Jun 19, 2014 |
| 6-K | Current report (foreign issuer) | Apr 21, 2014 | Jun 19, 2014 |
| 6-K | Current report (foreign issuer) | Mar 14, 2014 | Dec 31, 2013 |
| 20-F | Annual report (foreign issuer) | Mar 14, 2014 | Dec 31, 2013 |
| 6-K | Current report (foreign issuer) | Nov 14, 2013 | Sep 30, 2013 |
| UPLOAD | Letter from the SEC | Aug 15, 2013 | — |
| 6-K | Current report (foreign issuer) | Aug 14, 2013 | Jun 30, 2013 |
| CORRESP | Letter to the SEC | Aug 13, 2013 | — |
| UPLOAD | Letter from the SEC | Aug 6, 2013 | — |
| CORRESP | Letter to the SEC | Jul 31, 2013 | — |
| UPLOAD | Letter from the SEC | Jul 24, 2013 | — |
| CORRESP | Letter to the SEC | Jul 15, 2013 | — |
| UPLOAD | Letter from the SEC | Jul 5, 2013 | — |
| 6-K | Current report (foreign issuer) | May 15, 2013 | Mar 31, 2013 |
| 6-K/A | Report of foreign issuer for april 26, 2012 - amendment no.1 | Apr 26, 2013 | Jun 12, 2013 |
| 6-K | Current report (foreign issuer) | Apr 15, 2013 | Jun 12, 2013 |
| 20-F | Annual report (foreign issuer) | Mar 15, 2013 | Dec 31, 2012 |
| 6-K | Current report (foreign issuer) | Mar 15, 2013 | Dec 31, 2012 |
| 6-K | Current report (foreign issuer) | Jan 22, 2013 | Jan 22, 2013 |
| 6-K | Current report (foreign issuer) | Nov 14, 2012 | Sep 30, 2012 |
| 6-K | Current report (foreign issuer) | Aug 14, 2012 | Jun 30, 2012 |
| 6-K | Current report (foreign issuer) | May 15, 2012 | Mar 31, 2012 |
| 6-K | Current report (foreign issuer) | Apr 20, 2012 | Apr 20, 2012 |
| 6-K | Current report (foreign issuer) | Mar 15, 2012 | Dec 31, 2011 |
| 20-F | Annual report (foreign issuer) | Mar 15, 2012 | Dec 31, 2011 |
| 6-K | Current report (foreign issuer) | Mar 1, 2012 | Mar 1, 2012 |
| 6-K | Current report (foreign issuer) | Feb 21, 2012 | Feb 21, 2012 |
| 6-K | Current report (foreign issuer) | Nov 14, 2011 | Sep 30, 2011 |
| CT ORDER | Filing | Aug 26, 2011 | — |
| 6-K | Current report (foreign issuer) | Aug 12, 2011 | Jun 30, 2011 |
| 20-F/A | Amended annual report (foreign issuer) | Jun 3, 2011 | Dec 31, 2010 |
| 6-K | Current report (foreign issuer) | May 13, 2011 | Mar 31, 2011 |
| 6-K | Current report (foreign issuer) | Apr 21, 2011 | Apr 21, 2011 |
| 20-F | Annual report (foreign issuer) | Mar 15, 2011 | Dec 31, 2010 |
| 6-K | Current report (foreign issuer) | Mar 15, 2011 | Dec 31, 2010 |
| 6-K | Current report (foreign issuer) | Dec 17, 2010 | Dec 16, 2010 |
| 6-K | Current report (foreign issuer) | Nov 12, 2010 | Sep 30, 2010 |
| 6-K | Current report (foreign issuer) | Aug 13, 2010 | Jun 30, 2010 |
| 6-K | Current report (foreign issuer) | May 14, 2010 | Mar 31, 2010 |
| 6-K | Current report (foreign issuer) | Apr 23, 2010 | Jun 22, 2010 |
| 6-K | Current report (foreign issuer) | Mar 11, 2010 | Dec 31, 2009 |
| 20-F | Annual report (foreign issuer) | Mar 11, 2010 | Dec 31, 2009 |
| 6-K | Current report (foreign issuer) | Nov 13, 2009 | Sep 30, 2009 |
| 6-K | Current report (foreign issuer) | Aug 14, 2009 | Jun 30, 2009 |
| 6-K | Current report (foreign issuer) | Jun 3, 2009 | Mar 31, 2009 |
| 6-K | Current report (foreign issuer) | May 15, 2009 | Mar 31, 2009 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- In Vitro & In Vivo Diagnostic Substances (SIC 2835)
- Listed as
- NYMXF (OTC)
- Fiscal year ends
- December 31
- Headquarters
- Quebec Canada, Quebec, Canada
- SEC filer status
- Accelerated filer
- SEC CIK
- 1018735
Other In Vitro & In Vivo Diagnostic Substances companies
- Idexx Laboratories Inc /DE IDXX
- Lantheus Holdings, Inc. LNTH
- Neogen Corp NEOG
- Celldex Therapeutics, Inc. CLDX
- Intellia Therapeutics, Inc. NTLA
- QuidelOrtho Corp QDEL
- Achieve Life Sciences, Inc. ACHV
- Myriad Genetics Inc MYGN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.